From: Liraglutide and Dulaglutide therapy in addition to SGLT-2 inhibitor and metformin treatment in Indian type 2 diabetics: a real world retrospective observational study
Follow-up A1c < 7%
Total
p (2-sided)
No
Yes
Cohort
Dulaglutide
Number of Patients
21
9
30
0.019
%
70.0%
30.0%
100.0%
Liraglutide
11
19
36.7%
63.3%
32
28
60
53.3%
46.7%